197 related articles for article (PubMed ID: 11959588)
1. Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
Vaudaux P; Francois P; Bisognano C; Schrenzel J; Lew DP
Antimicrob Agents Chemother; 2002 May; 46(5):1503-9. PubMed ID: 11959588
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Cagni A; Chuard C; Vaudaux PE; Schrenzel J; Lew DP
Antimicrob Agents Chemother; 1995 Aug; 39(8):1655-60. PubMed ID: 7486895
[TBL] [Abstract][Full Text] [Related]
3. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
Schaad HJ; Chuard C; Vaudaux P; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1994 Aug; 38(8):1703-10. PubMed ID: 7985998
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
[TBL] [Abstract][Full Text] [Related]
5. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1997 Aug; 41(8):1662-7. PubMed ID: 9257737
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
Lucet JC; Herrmann M; Rohner P; Auckenthaler R; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1990 Dec; 34(12):2312-7. PubMed ID: 2128441
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
Trampuz A; Murphy CK; Rothstein DM; Widmer AF; Landmann R; Zimmerli W
Antimicrob Agents Chemother; 2007 Jul; 51(7):2540-5. PubMed ID: 17502404
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus.
Schaad HJ; Chuard C; Vaudaux P; Rohner P; Waldvogel FA; Lew DP
J Antimicrob Chemother; 1994 Jun; 33(6):1191-200. PubMed ID: 7928812
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Palmer SM; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):701-5. PubMed ID: 8851596
[TBL] [Abstract][Full Text] [Related]
11. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
Baldoni D; Haschke M; Rajacic Z; Zimmerli W; Trampuz A
Antimicrob Agents Chemother; 2009 Mar; 53(3):1142-8. PubMed ID: 19075065
[TBL] [Abstract][Full Text] [Related]
12. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
Patel MV; De Souza NJ; Gupte SV; Jafri MA; Bhagwat SS; Chugh Y; Khorakiwala HF; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Dec; 48(12):4754-61. PubMed ID: 15561853
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Drago L; De Vecchi E; Nicola L; Gismondo MR
BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
[TBL] [Abstract][Full Text] [Related]
14. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
Chuard C; Herrmann M; Vaudaux P; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1991 Dec; 35(12):2611-6. PubMed ID: 1810196
[TBL] [Abstract][Full Text] [Related]
15. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
Dalhoff A; Schubert S
Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.
Vaudaux P; Francois P; Bisognano C; Li D; Lew DP; Schrenzel J
J Antimicrob Chemother; 2003 Jul; 52(1):89-95. PubMed ID: 12775678
[TBL] [Abstract][Full Text] [Related]
17. Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin.
Bouchenaki N; Vaudaux PE; Huggler E; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1990 Jan; 34(1):21-4. PubMed ID: 2109574
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
Kang SL; Rybak MJ; McGrath BJ; Kaatz GW; Seo SM
Antimicrob Agents Chemother; 1994 Dec; 38(12):2702-9. PubMed ID: 7695250
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
Schaad HJ; Bento M; Lew DP; Vaudaux P
BMC Infect Dis; 2006 Apr; 6():74. PubMed ID: 16608512
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
Frosco MB; Melton JL; Stewart FP; Kulwich BA; Licata L; Barrett JF
Antimicrob Agents Chemother; 1996 Nov; 40(11):2529-34. PubMed ID: 8913458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
